FindTrial
Sign In

Medical records based retrospective study for the effect of blood uric acid in the clinical treatment of AS patients

Study on the effect of blood uric acid in the clinical treatment of AS patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037279
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-08-15
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing spondylitis

Interventions

Ankylosing spondylitis group:Nil
Healthy control group:Nil

Sponsors

East Hospital of Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) In accordance with the revised AS classification standard established by the New York Rheumatology society in 1984; (2) Aged 16 years old or more; (3) the relevant data records are timely, complete and accurate.

Exclusion criteria

Exclusion criteria: Diabetes, primary hypertension and primary glomerulonephritis, renal tubular disease, urinary tract infection, lupus nephritis, myeloma nephropathy, acute stage infection, tumor and exclusion of other connective tissue diseases.

Design outcomes

Primary

MeasureTime frame
clinical indexes;Serum uric acid;—

Secondary

MeasureTime frame
eGFR;24-hour urine protein;—

Countries

China

Contacts

Public ContactYan Wu

East Hospital of Shanghai Sixth People's Hospital

swallow1623@163.com+86 15216618208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026